Look for:

Our offer for

GILEAD SCIENCES INC.


ISIN:
US3755581036
WKN:
375558103

2022/01/27 09:06:29
Price
66.985 USD
Difference -1.37% (-0.93)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeLondon Stock Exchange European Trade Reporting
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)75,148 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)64.76 USD (1,500)
Ask (Ask size)70.78 USD (500)
Open66.985 USD
High66.985 USD
Low66.985 USD
Close (prev. day)67.915 USD
VWAP68.97 USD
Volume (pcs)-
Trading volume-
Number of trades1
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/01/27 09:06:29
Price
66.985 USD
Difference -1.37% (-0.93)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeLondon Stock Exchange European Trade Reporting
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)75,148 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)64.76 USD (1,500)
Ask (Ask size)70.78 USD (500)
Open66.985 USD
High66.985 USD
Low66.985 USD
Close (prev. day)67.915 USD
VWAP68.97 USD
Volume (pcs)-
Trading volume-
Number of trades1
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-1.52%+0.34%-1.91%
Perf (abs.)-1.05+0.23-1.33
Beta0.310.350.51
Volatility16.1718.1525.61
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)68.521 USD (164)
Ø price 30 days | Ø volume 30 days (pcs.)71.257 USD (41,778)
Ø price 100 days | Ø volume 100 days (pcs.)69.538 USD (23,632)
Ø price 250 days | Ø volume 250 days (pcs.)68.086 USD (14,698)
YTD High | date72.785 USD (2022/01/04)
YTD Low | date67.595 USD (2022/01/26)
52 Weeks High | date73.645 USD (2021/12/30)
52 Weeks Low | date61.775 USD (2021/02/26)

All listings for GILEAD SCIENCES INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/01/2711:5060.15 EUR0.1545
Vienna Stock Exchange2022/01/2709:0659.59 EUR0.012
Tradegate2022/01/2711:4760.30 EUR0.1527
Stuttgart2022/01/2709:4760.00 EUR0.012
SIX Swiss Exchange2020/04/1717:3585.00 USD0.001
SIX Swiss Exchange2020/05/1117:3572.00 CHF0.001
Nasdaq2022/01/2622:0067.34 USD763.35120,812
Munich2022/01/2708:0159.65 EUR0.001
London Stock Exchange European Trade Reporting2022/01/2709:0666.985 USD0.001
Hanover2022/01/2708:1259.50 EUR0.001
Hamburg2022/01/2708:1259.50 EUR0.001
Frankfurt2022/01/2711:5360.25 EUR0.012
Duesseldorf2022/01/2711:0060.02 EUR0.004
Borsa Italiana MTF Trading After Hours2021/12/2019:4264.39 EUR0.011
Borsa Italiana MTF Global Equity Market2022/01/2617:3560.22 EUR0.1019
Berlin2022/01/2708:0859.47 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1964&ID_TYPE_IMAGE_LOGO=2

Contact Details

GILEAD SCIENCES INC.
- -
333 Lakeside Drive - 94404 Foster City
Telefon: 1-650-574-3000
Fax: 1-650-578-9264
E-mail: -

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Members of Management Board

Jacqueline BartonMember of Board of Directors
Jeffrey BluestoneMember of Board of Directors
Sandra HorningMember of Board of Directors
Anthony WeltersMember of Board of Directors
Harish M. ManwaniMember of Board of Directors
Javier RodriguezMember of Board of Directors
Kelly KramerMember of Board of Directors
Kevin LoftonMember of Board of Directors
Daniel OšDayChairman of Managing Board
Merdad ParseyMember of Executive Committee
Taiyin YangMember of Executive Committee
Andrew DickinsonMember of Executive Committee
Brett PletcherMember of Executive Committee
Christi L. ShawMember of Executive Committee
Flavius MartinMember of Executive Committee
Johanna MercierMember of Executive Committee
Jyoti MehraMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer